Satoshi HoshideKazuomi KarioNaoko TomitaniTomoyuki KabutoyaYook Chin ChiaSungha ParkJinho ShinYuda TuranaJam Chin TayPeera BuranakitjaroenChen Huan ChenJennifer NailesHuynh Van MinhSaulat SiddiqueJorge SisonArieska Ann SoenartaGuru Prasad SogunuruApichard SukonthasarnBoon Wee TeoNarsingh VermaYuqing ZhangTzung Dau WangJi Guang WangUniversity Medicine and Pharmacy, Hue UniversityDe La Salle Health Sciences InstituteSunway UniversityHanyang University Medical CenterJichi Medical UniversityYonsei University Health SystemShanghai Jiao Tong University School of MedicineMadras Institute of Orthopaedics and Traumatology HospitalsNational Taiwan University HospitalKathmandu UniversityUniversity of the East Ramon Magsaysay Memorial Medical CenterFatima Memorial HospitalNational Yang-Ming University TaiwanUniversitas Katolik Indonesia Atma JayaUniversitas IndonesiaUniversity of MalayaFuwai Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical CollegeYong Loo Lin School of MedicineKing George's Medical UniversityFaculty of Medicine, Siriraj Hospital, Mahidol UniversityTan Tock Seng HospitalBangkok Hospital Chiang Mai2020-05-052020-05-052020-03-01Journal of Clinical Hypertension. Vol.22, No.3 (2020), 369-37717517176152461752-s2.0-85077889100https://repository.li.mahidol.ac.th/handle/20.500.14594/54627© 2019 Wiley Periodicals, Inc. Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines (“JSH 2019”) continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.Mahidol UniversityMedicineReviewSCOPUS10.1111/jch.13763